Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

8035 items from SEC EDGAR · clear filters

  • SEC EDGAR•filings
    8-K - AETHLON MEDICAL INC (0000882291) (Filer)

    Automated noteAethlon Medical Inc. filed a Form 8-K on September 15, 2026 reporting the departure and appointment of certain officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGAR•filings
    8-K - Otis Worldwide Corp (0001781335) (Filer)

    Automated noteOtis Worldwide Corp filed a Form 8-K on September 15, 2026, disclosing departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Coya Therapeutics, Inc. (0001835022) (Filer)

    Automated noteCoya Therapeutics, Inc. filed a Form 8-K under Item 8.01 (Other Events) with the SEC on September 15, 2026 (Accession No. 0001193125-26-391378).

  • SEC EDGAR•filings
    8-K - INTRUSION INC (0000736012) (Filer)

    Automated noteIntrusion Inc filed a Form 8-K on September 15, 2026 reporting the departure, election, or appointment of certain directors or officers and related compensatory arrangements.

  • SEC EDGAR•filings
    8-K - Vera Bradley, Inc. (0001495320) (Filer)

    Automated noteVera Bradley, Inc. filed a Form 8-K on September 15, 2026, including Item 2.02 reporting its results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - EIDP, Inc. (0000030554) (Filer)

    Automated noteEIDP, Inc. filed a Form 8-K with the SEC on September 15, 2026 (Accession No. 0001193125-26-391369), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Corteva, Inc. (0001755672) (Filer)

    Automated noteCorteva, Inc. submitted a Form 8-K on September 15, 2026 (Accession No. 0001193125-26-391369) containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - RB GLOBAL INC. (0001046102) (Filer)

    Automated noteRB Global Inc. filed a Form 8-K on September 15, 2026, reporting other events and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - LB PHARMACEUTICALS INC (0001691082) (Filer)

    Automated noteLB Pharmaceuticals filed a Form 8-K on September 15, 2026, reporting director/officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - NextTrip, Inc. (0000788611) (Filer)

    Automated noteNextTrip, Inc. filed a Form 8-K on September 15, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Sadot Group Inc. (0001701756) (Filer)

    Automated noteSadot Group Inc. filed a Form 8-K reporting a material definitive agreement, changes to directors and officers with related compensation arrangements, amendments to its articles and bylaws, a shareholder vote, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - CHEETAH NET SUPPLY CHAIN SERVICE INC. (0001951667) (Filer)

    Automated noteCheetah Net Supply Chain Service Inc. filed a Form 8-K on September 15, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - ASPEN AEROGELS INC (0001145986) (Filer)

    Automated noteAspen Aerogels Inc. filed a Form 8-K on September 15, 2026, reporting a Regulation FD disclosure and providing its financial statements and related exhibits as required under Items 7.01 and 9.01.

  • SEC EDGAR•filings
    8-K - Quality Industrial Corp. (0001393781) (Filer)

    Automated noteQuality Industrial Corp. filed a Form 8-K on September 15, 2026, reporting amendments to its articles of incorporation or bylaws and a change in its fiscal year, and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Cushman & Wakefield Ltd. (0001628369) (Filer)

    Automated noteCushman & Wakefield Ltd. filed a Form 8-K on September 15, 2026, disclosing departures, elections, appointments and compensatory arrangements for certain officers, and included its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - LINDBLAD EXPEDITIONS HOLDINGS, INC. (0001512499) (Filer)

    Automated noteLindblad Expeditions Holdings filed a Form 8-K on September 15, 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and including financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - QUANTUM X LABS INC. (0000797542) (Filer)

    Automated noteQuantum X Labs Inc. submitted a Form 8-K on September 15, 2026 (Accession No. 0001493152-26-042665), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Zeo ScientifiX, Inc. (0001557376) (Filer)

    Automated noteZeo ScientifiX, Inc. filed a Form 8-K on September 15, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - AMERICAN EXPRESS CO (0000004962) (Filer)

    Automated noteAmerican Express filed a Form 8-K with the SEC on September 15, 2026, under Item 7.01, providing a Regulation FD disclosure.

  • SEC EDGAR•filings
    8-K - BlossomHill Therapeutics, Inc. (0001839970) (Filer)

    Automated noteBlossomHill Therapeutics, Inc. filed a Form 8-K on September 15, 2026, which includes a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - AXON ENTERPRISE, INC. (0001069183) (Filer)

    Automated noteAxon Enterprise filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Driven Brands Holdings Inc. (0001804745) (Filer)

    Automated noteDriven Brands Holdings Inc. filed a Form 8-K on September 15, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - FibroBiologics, Inc. (0001958777) (Filer)

    Automated noteFibroBiologics, Inc. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, and the inclusion of financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - ROCKET PHARMACEUTICALS, INC. (0001281895) (Filer)

    Automated noteRocket Pharmaceuticals, Inc. filed an 8-K with the SEC on September 15 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Connect Biopharma Holdings Ltd (0001835268) (Filer)

    Automated noteConnect Biopharma Holdings Ltd filed a Form 8-K on September 15, 2026 (AccNo 0001835268-26-000034, 2 MB), including a Regulation FD disclosure, other events, and financial statements with accompanying exhibits.

  • SEC EDGAR•filings
    8-K - D-Wave Quantum Inc. (0001907982) (Filer)

    Automated noteD-Wave Quantum Inc. filed a Form 8-K on September 15, 2026, reporting a Regulation FD disclosure and providing its financial statements and related exhibits as required under Items 7.01 and 9.01.

  • SEC EDGAR•filings
    8-K - BREAD FINANCIAL HOLDINGS, INC. (0001101215) (Filer)

    Automated noteBread Financial Holdings, Inc. filed a Form 8-K on September 15, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - TRUIST FINANCIAL CORP (0000092230) (Filer)

    Automated noteTruist Financial Corp filed a Form 8-K on September 15, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Piedmont Realty Trust, Inc. (0001042776) (Filer)

    Automated notePiedmont Realty Trust filed a Form 8-K on September 15, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Vera Therapeutics, Inc. (0001831828) (Filer)

    Automated noteVera Therapeutics, Inc. filed a Form 8-K on September 15, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.